BETHESDA, Md., July 2, 2025 /PRNewswire/ -- Centrus Energy Corp. (NYSE American: LEU) today announced that management will participate in the following upcoming conferences.
...
SAN DIEGO, July 2, 2025 /PRNewswire/ -- A new prospective study published in BMC Cancer demonstrates that a novel blood-based multi-omics test, SeekInClarity, can accurately...
Rotation Two Underway
Trading Symbol - TSXV: NAR
VANCOUVER, BC, July 2, 2025 /CNW/ - North Arrow Minerals Inc. (TSXV: NAR) is executing a breakthrough exploration program...
VANCOUVER, BC, July 2, 2025 /CNW/ - NGEx Minerals Ltd. ("NGEx", "NGEx Minerals" or the "Company") (TSX: NGEX) (OTCQX: NGXXF) is pleased to announce additional...
Recruitment initiated into the Phase 2 opaganib plus darolutamide study in patients with advanced prostate cancer, sponsored by ANZUP, and supported by Bayer and...
Market Growth Driven by Rising Demand for Point-of-Care Diagnostics, Increasing Prevalence of Chronic and Infectious Diseases, Emergency Department Needs, and Technological Innovations
REDDING, Calif., June...
/NOT FOR DISTRIBUTION TO US NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR...
PALM BEACH, Fla., June 27, 2025 (GLOBE NEWSWIRE) -- Today marks a significant milestone for theranos and its diagnostic technology. The theranos system performs automated sample processing and analysis to produce clinical test results. The U.S. Food and Drug Administration’s Center for Devices and Radiological Health (CDRH) has affirmed that the core technology is not under question.